Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1989 2
1990 2
1991 2
1992 3
1993 3
1994 6
1995 5
1996 3
1997 12
1998 4
1999 1
2000 5
2001 8
2002 5
2003 3
2004 6
2005 8
2006 2
2007 1
2008 4
2009 2
2010 5
2011 4
2012 5
2013 4
2014 5
2015 3
2016 1
2017 3
2018 2
2019 4
2020 3
2021 7
2022 6
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM; TRAILBLAZER-ALZ 2 Investigators. Sims JR, et al. JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239. JAMA. 2023. PMID: 37459141 Free PMC article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
[Preface].
Yoshiyama Y, Akita M. Yoshiyama Y, et al. Nihon Yakurigaku Zasshi. 2022;157(5):325. doi: 10.1254/fpj.22051. Nihon Yakurigaku Zasshi. 2022. PMID: 36047145 Japanese. No abstract available.
Polygenic effects on the risk of Alzheimer's disease in the Japanese population.
Kikuchi M, Miyashita A, Hara N, Kasuga K, Saito Y, Murayama S, Kakita A, Akatsu H, Ozaki K, Niida S, Kuwano R, Iwatsubo T, Nakaya A, Ikeuchi T; Alzheimer’s Disease Neuroimaging Initiative; Japanese Alzheimer’s Disease Neuroimaging Initiative. Kikuchi M, et al. Alzheimers Res Ther. 2024 Feb 27;16(1):45. doi: 10.1186/s13195-024-01414-x. Alzheimers Res Ther. 2024. PMID: 38414085 Free PMC article.
Consensus guidance of nebulizer therapy for acute rhinosinusitis.
Ohki M, Hyo Y, Yoshiyama Y, Takano H, Takahata J, Suzuki M, Takeno S, Ogoshi T, Suzuki K, Takeuchi K, Naito K, Haruna S, Fujisawa T, Yamaguchi S, Hotomi M, Kawauchi H, Kurono Y; working group of the Japan Society for Infection and Aerosol in Otorhinolaryngology. Ohki M, et al. Among authors: yoshiyama y. Auris Nasus Larynx. 2020 Feb;47(1):18-24. doi: 10.1016/j.anl.2019.08.007. Epub 2019 Aug 31. Auris Nasus Larynx. 2020. PMID: 31477344
Therapeutic strategies for tau mediated neurodegeneration.
Yoshiyama Y, Lee VM, Trojanowski JQ. Yoshiyama Y, et al. J Neurol Neurosurg Psychiatry. 2013 Jul;84(7):784-95. doi: 10.1136/jnnp-2012-303144. Epub 2012 Oct 20. J Neurol Neurosurg Psychiatry. 2013. PMID: 23085937 Free PMC article. Review.
Frontotemporal dementia and tauopathy.
Yoshiyama Y, Lee VM, Trojanowski JQ. Yoshiyama Y, et al. Curr Neurol Neurosci Rep. 2001 Sep;1(5):413-21. doi: 10.1007/s11910-001-0100-0. Curr Neurol Neurosci Rep. 2001. PMID: 11898551 Review.
Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer's disease patients.
Kondo T, Hara N, Koyama S, Yada Y, Tsukita K, Nagahashi A, Ikeuchi T, Ishii K, Asada T, Arai T, Yamada R; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI); Inoue H. Kondo T, et al. Nat Aging. 2022 Feb;2(2):125-139. doi: 10.1038/s43587-021-00158-9. Epub 2022 Feb 17. Nat Aging. 2022. PMID: 37117761
144 results